Verzenio-Faslodex combo prolongs survival in advanced breast cancer, interim phase 3 data show August 2, 2019
Novartis Kisqali (ribociclib) significantly prolongs life in women with HR+/HER2- advanced breast cancer now in two distinct Phase III trials July 31, 2019
Pairing targeted drugs for breast & lung cancer could overcome treatment resistance (See original publication below) July 11, 2019
Original publication: Signalling involving MET & FAK supports cell division independent of the activity of the cell cycle-regulating CDK4/6 kinases July 11, 2019 0
Death effector domain-containing protein induces vulnerability to cell cycle inhibition in TNBC June 28, 2019
Palbociclib with letrozole in postmenopausal women with ER+/HER2−neg advanced breast cancer: hematologic safety analysis of the randomized PALOMA-2 trial June 19, 2019